Valo Therapeutics Acquires University Of Helsinki's Peptibac Cancer And Infectious Disease Vaccination Technology

by prnewswire.com posted 5months ago 156 views
HELSINKI, April 19, 2021 /PRNewswire/ -- Valo Therapeutics Limited (Valo Tx), the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases, today announced the acquisition of intellectual property rights for the proprietary 'PeptiBAC' technology from the...

In this article